# The Efficacy and Safety of Invossa K Injection in Patients Diagnosed With Knee Osteoarthritis

> **NCT03383471** · PHASE3 · UNKNOWN · sponsor: **Kolon Life Science** · enrollment: 146 (estimated)

## Conditions studied

- Osteoarthritis

## Interventions

- **BIOLOGICAL:** Invossa K Inj.
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03383471
- **Lead sponsor:** Kolon Life Science
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-12
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-03-30
- **Target enrollment:** 146 (ESTIMATED)
- **Last updated:** 2018-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03383471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03383471, "The Efficacy and Safety of Invossa K Injection in Patients Diagnosed With Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03383471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*